N. Deschamps, X. Ricaud, G. Rabut, A. Labbe, C. Baudouin et al., The Impact of Dry Eye Disease on Visual Performance While Driving, American Journal of Ophthalmology, vol.156, issue.1, pp.184-189, 2013.
DOI : 10.1016/j.ajo.2013.02.019

A. Labbe, Y. X. Wang, Y. Jie, C. Baudouin, J. B. Jonas et al., Dry eye disease, dry eye symptoms and depression: the Beijing Eye Study, British Journal of Ophthalmology, vol.39, issue.11, pp.1399-1403, 2003.
DOI : 10.1093/ageing/afp187

B. D. Sullivan, L. A. Crews, E. M. Messmer, G. N. Foulks, K. K. Nichols et al., Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications, Acta Ophthalmologica, vol.24, issue.2, pp.161-166, 2014.
DOI : 10.1097/01.ico.0000178740.14212.1a

A. J. Bron, C. S. De-paiva, S. K. Chauhan, S. Bonini, E. E. Gabison et al., TFOS DEWS II pathophysiology report, The Ocular Surface, vol.15, issue.3, pp.438-510, 2017.
DOI : 10.1016/j.jtos.2017.05.011

F. Brignole-baudouin, L. Riancho, D. Ismail, M. Deniaud, M. Amrane et al., Correlation Between the Inflammatory Marker HLA-DR and Signs and Symptoms in Moderate to Severe Dry Eye Disease, Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease. Investig. Ophthalmol. Vis. Sci. 2012, pp.2438-2448
DOI : 10.1167/iovs.15-16555

R. Goazigo, A. Rivat, C. Kitabgi, P. Pohl, and M. , Cellular and subcellular localization of CXCL12 and CXCR4 in rat nociceptive structures: physiological relevance, CrossRef] [PubMed] 9. Van Steenwinckel, pp.2619-2631, 2012.
DOI : 10.1523/JNEUROSCI.2209-07.2007

M. Parsadaniantz and S. , Stromal cell-derived CCL2 drives neuropathic pain states through myeloid cell infiltration in injured nerve, Brain Behav. Immun. 2015, vol.45, pp.198-210

J. Van-steenwinckel, A. Reaux-le-goazigo, B. Pommier, A. Mauborgne, M. A. Dansereau et al., Melik Parsadaniantz, S. CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury, J. Neurosci, pp.31-5865, 2011.

M. Parsadaniantz, S. Rivat, C. Rostene, and W. , Opioid and chemokine receptor crosstalk: a promising target for pain therapy?, Nature Reviews Neuroscience, vol.20, issue.2, pp.69-78, 2015.
DOI : 10.1016/j.bbi.2013.11.010

L. Basso, J. Boue, K. Mahiddine, C. Blanpied, S. Robiou-du-pont et al., Endogenous analgesia mediated by CD4+ T lymphocytes is dependent on enkephalins in mice, Journal of Neuroinflammation, vol.5, issue.1, p.132, 2016.
DOI : 10.3389/fphar.2014.00262

URL : https://hal.archives-ouvertes.fr/inserm-01324419

B. P. Roques, M. C. Fournie-zaluski, and M. Wurm, Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain. Nature reviews. Drug Discov, pp.292-310, 2012.

C. Stein and S. Kuchler, Targeting inflammation and wound healing by opioids, Trends in Pharmacological Sciences, vol.34, issue.6, pp.303-312
DOI : 10.1016/j.tips.2013.03.006

H. Poras, E. Bonnard, E. Dange, M. C. Fournie-zaluski, and B. Roques, New Orally Active Dual Enkephalinase Inhibitors (DENKIs) for Central and Peripheral Pain Treatment, Journal of Medicinal Chemistry, vol.57, issue.13, pp.5748-5763, 2014.
DOI : 10.1021/jm500602h

C. Stein and S. Kuchler, Non-Analgesic Effects of Opioids: Peripheral Opioid Effects on Inflammation and Wound Healing, Current Pharmaceutical Design, vol.18, issue.37, pp.6053-6069
DOI : 10.2174/138161212803582513

C. F. Marfurt, J. Cox, S. Deek, and L. Dvorscak, Anatomy of the human corneal innervation, Experimental Eye Research, vol.90, issue.4, pp.478-492, 2010.
DOI : 10.1016/j.exer.2009.12.010

C. Belmonte, J. J. Nichols, S. M. Cox, J. A. Brock, C. G. Begley et al., TFOS DEWS II pain and sensation report, The Ocular Surface, vol.15, issue.3, pp.2017-404
DOI : 10.1016/j.jtos.2017.05.002

M. C. Acosta, C. Luna, S. Quirce, C. Belmonte, and J. Gallar, Changes in sensory activity of ocular surface sensory nerves during allergic keratoconjunctivitis, Pain, vol.154, issue.11, pp.2353-2362
DOI : 10.1016/j.pain.2013.07.012

S. Barabino, E. Montaldo, F. Solignani, C. Valente, M. C. Mingari et al., Immune response in the conjunctival epithelium of patients with dry eye, Experimental Eye Research, vol.91, issue.4, pp.524-529, 2010.
DOI : 10.1016/j.exer.2010.07.008

C. Baudouin, H. Liang, D. Bremond-gignac, P. Hamard, R. Hreiche et al., CCR4 and CCR5 expression in conjunctival specimens as differential markers of TH1/ TH2 in ocular surface disorders, Journal of Allergy and Clinical Immunology, vol.116, issue.3, pp.614-619, 2005.
DOI : 10.1016/j.jaci.2005.05.033

C. Rivat, S. Sebaihi, J. Van-steenwinckel, S. Fouquet, P. Kitabgi et al., Src family kinases involved in CXCL12-induced loss of acute morphine analgesia, Brain, Behavior, and Immunity, vol.38, pp.38-52, 2014.
DOI : 10.1016/j.bbi.2013.11.010

S. Goyal, S. K. Chauhan, Q. Zhang, and R. Dana, Amelioration of Murine Dry Eye Disease by Topical Antagonist to Chemokine Receptor 2, Archives of Ophthalmology, vol.127, issue.7, pp.882-887, 2009.
DOI : 10.1001/archophthalmol.2009.125

J. W. Berman, M. P. Guida, J. Warren, J. Amat, and C. Brosnan, Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat, J. Immunol, vol.156, pp.3017-3023, 1996.

N. M. Wilson, H. Jung, M. S. Ripsch, R. J. Miller, and F. A. White, CXCR4 signaling mediates morphine-induced tactile hyperalgesia, Brain, Behavior, and Immunity, vol.25, issue.3, pp.565-573, 2011.
DOI : 10.1016/j.bbi.2010.12.014

J. Dieckow, W. Brandt, K. Hattermann, S. Schob, U. Schulze et al., CXCR4 and CXCR7 Mediate TFF3-Induced Cell Migration Independently From the ERK1

S. Pathway, Investig. Ophthalmol. Vis. Sci, vol.2016, issue.57, pp.56-65

L. Sánchez-martín, A. Estecha, R. Samaniego, S. Sánchez-ramón, M. Á. Vega et al., The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression, Blood, vol.117, issue.1, pp.88-97, 2011.
DOI : 10.1182/blood-2009-12-258186

R. L. Farris, Tear Osmolarity ??? A New Gold Standard?, Adv. Exp. Med. Biol, vol.350, pp.495-503, 1994.
DOI : 10.1007/978-1-4615-2417-5_83

J. P. Gilbard, R. L. Farris, and J. Santamaria, Osmolarity of Tear Microvolumes in Keratoconjunctivitis Sicca, Archives of Ophthalmology, vol.96, issue.4, pp.677-681, 1978.
DOI : 10.1001/archopht.1978.03910050373015

C. Clouzeau, D. Godefroy, L. Riancho, W. Rostene, and C. Baudouin, Brignole-Baudouin, F. Hyperosmolarity potentiates toxic effects of benzalkonium chloride on conjunctival epithelial cells in vitro, Mol. Vis, vol.18, pp.851-863, 2012.

E. Warcoin, C. Clouzeau, C. Roubeix, A. L. Raveu, D. Godefroy et al.,

F. Brignole-baudouin, Hyperosmolarity and benzalkonium chloride differently stimulate inflammatory markers in conjunctiva-derived epithelial cells in vitro, Ophthalmic Res, vol.2017, issue.58, pp.40-48

I. Szabo, X. H. Chen, L. Xin, M. W. Adler, O. M. Howard et al., Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain, Proc. Natl. Acad. Sci, pp.10276-10281, 2002.
DOI : 10.1016/S0304-3959(99)00262-6

X. Chen, E. B. Geller, T. J. Rogers, and M. W. Adler, Rapid heterologous desensitization of antinociceptive activity between mu or delta opioid receptors and chemokine receptors in rats, Drug and Alcohol Dependence, vol.88, issue.1, pp.36-41, 2007.
DOI : 10.1016/j.drugalcdep.2006.09.010

P. J. Cabot, L. Carter, M. Schafer, and C. Stein, Methionine-enkephalin-and Dynorphin A-release from immune cells and control of inflammatory pain, Pain, vol.93, issue.3, pp.207-212, 2001.
DOI : 10.1016/S0304-3959(01)00322-0

M. Schafer, L. Carter, and C. Stein, Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue., Proc. Natl. Acad. Sci, pp.4219-4223, 1994.
DOI : 10.1073/pnas.91.10.4219

S. A. Mousa, M. Shakibaei, N. Sitte, M. Schafer, and C. Stein, Subcellular Pathways of ??-Endorphin Synthesis, Processing, and Release from Immunocytes in Inflammatory Pain, Endocrinology, vol.145, issue.3, pp.1331-1341, 2004.
DOI : 10.1210/en.2003-1287

F. Stapleton, M. Alves, V. Y. Bunya, I. Jalbert, K. Lekhanont et al., TFOS DEWS II Epidemiology Report, The Ocular Surface, vol.15, issue.3, pp.334-365, 2017.
DOI : 10.1016/j.jtos.2017.05.003

R. M. Schiffman, M. D. Christianson, G. Jacobsen, J. D. Hirsch, and B. L. Reis, Reliability and Validity of the Ocular Surface Disease Index, Archives of Ophthalmology, vol.118, issue.5, pp.615-621, 2000.
DOI : 10.1001/archopht.118.5.615

A. J. Bron, V. E. Evans, and J. A. Smith, Grading Of Corneal and Conjunctival Staining in the Context of Other Dry Eye Tests, Cornea, vol.22, issue.7, pp.640-650, 2003.
DOI : 10.1097/00003226-200310000-00008

A. Labbe, Q. Liang, Z. Wang, Y. Zhang, L. Xu et al., Corneal Nerve Structure and Function in Patients With Non-Sj??gren Dry Eye: Clinical Correlations, Investigative Opthalmology & Visual Science, vol.54, issue.8, pp.5144-5150, 2013.
DOI : 10.1167/iovs.13-12370

L. Tong, Y. Diebold, M. Calonge, J. Gao, M. E. Stern et al., Comparison of Gene Expression Profiles of Conjunctival Cell Lines With Primary Cultured Conjunctival Epithelial Cells and Human Conjunctival Tissue, Gene Expression, vol.14, issue.5, pp.265-278, 2009.
DOI : 10.3727/105221609788681231

Q. Zheng, Y. Ren, P. S. Reinach, B. Xiao, H. Lu et al., Reactive oxygen species activated NLRP3 inflammasomes initiate inflammation in hyperosmolarity stressed human corneal epithelial cells and environment-induced dry eye patients, Experimental Eye Research, vol.134, pp.133-140, 2015.
DOI : 10.1016/j.exer.2015.02.013

, This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http, Licensee MDPI